Global Bioprocessing Technology Market Size and Forecast 2024-2033|Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Lonza Group AG

The Bioprocessing Technology Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Bioprocessing Technology Market:

https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report

According to The Business Research Company’s Bioprocessing Technology Global Market Report 2024, The bioprocessing technology market size has grown rapidly in recent years. It will grow from $21.74 billion in 2023 to $25.22 billion in 2024 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, expansion of biotechnology and life sciences industries, growing investment in research and development, globalization of the biopharmaceutical market, focus on cost-efficiency and process optimization

The bioprocessing technology market size is expected to see rapid growth in the next few years. It will grow to $43.22 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to biomanufacturing capacity expansion, emergence of advanced therapies, rising importance of single-use bioprocessing systems, increased adoption of continuous bioprocessing, strategic collaborations and partnerships. Major trends in the forecast period include personalized medicine and precision bioprocessing, regulatory compliance and quality assurance, global expansion of biopharmaceutical production, environmental sustainability, collaborations and partnerships.

The increased incidences of chronic diseases are expected to propel the growth of the bioprocessing technology market going forward. Chronic diseases are long-term health disorders that endure for at least a year and impair daily activities, require continuing medical care, or both. The bioprocessing technologies involves the discoveries of therapeutic proteins, polysaccharides, vaccines, and diagnostics essentials for the treatment of chronic diseases. Hence, the increased incidence of chronic diseases will support the growth of the bioprocessing technology market. For instance, in 2023, according to a report published by National Library of Medicine, a US-based medical journal, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. Moreover, in the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.52 million in 2020 to 142.66 million by 2050. Therefore, the increased incidences of chronic diseases will drive the growth of the bioprocessing technology market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10540&type=smp

The bioprocessing technology market covered in this report is segmented –

1) By Product: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration

2) By Application: Antibiotics, Biosimilars, Recombinant Proteins, Other Applications

3) By End Use: Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed Industry, Contract Research Organization

Advancement in bioprocessing technology is a key trend gaining popularity in the bioprocessing technology market. Major companies operating in the bioprocess technology market are focusing on advancement in bioprocess technologies to sustain their position in the market. For instance, in October 2022, Univercells Technologies Inc., a Belgium-based biotechnology company, launched new scale-x technology, scale-X cell collect module. This innovative solution looks to facilitate the inoculation stage for large-scale bioreactors by utilizing the concepts of automation and intensification. The scale-X is designed to lower aseptic risk and provide high repeatability while reducing expenses, operating time, and footprint.

The bioprocessing technology market report table of contents includes:

1. Executive Summary

2. Bioprocessing Technology Market Characteristics

3. Bioprocessing Technology Market Trends And Strategies

4. Bioprocessing Technology Market – Macro Economic Scenario

5. Global Bioprocessing Technology Market Size and Growth

26. South America Bioprocessing Technology Market

27. Brazil Bioprocessing Technology Market

28. Middle East Bioprocessing Technology Market

29. Africa Bioprocessing Technology Market

30. Bioprocessing Technology Market Competitive Landscape And Company Profiles

Top Major Players: